AI assistant
Hester Biosciences Ltd — Call Transcript 2025
Jan 23, 2025
62222_rns_2025-01-23_31cdacab-9d92-4fe1-94eb-00cb7ea681cc.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [596 x 111] intentionally omitted <==
23 January 2025
To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001
To, National Stock Exchange of India Limited
Exchange Plaza, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051
Scrip Code: 524669
Symbol: HESTERBIO
Dear Sir/ Madam:
Subject: Intimation of earnings conference call
This is to inform you that, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has scheduled investor interaction through a teleconference call on Thursday, 30 January 2025 at 2:00 p.m. (IST), post the announcement of financial results for the quarter and nine months period ended 31 December 2024. Details for joining the call are attached herewith.
You are requested to take the above on record.
Sincerely For Hester Biosciences Limited
Vinod Digitally signed by Vinod Mali Date: 2025.01.23 Mali 13:53:11 +05'30'
Vinod Mali
Company Secretary & Compliance Officer
Enclosure: As above
==> picture [182 x 25] intentionally omitted <==
is pleased to invite you to the
Q3 & 9M FY25 Results Conference Call
of
==> picture [73 x 73] intentionally omitted <==
Hester Biosciences Limited
Represented by \
Mr. Rajiv Gandhi, CEO & Managing Director Ms. Priya Gandhi, Executive Director Mr. Divyesh Maru, Chief Financial Officer
on
Thursday, January 30, 2025
at 14:00 hrs India Time
Diamond Pass registration link: Copy this Link in your browser: Link
Call Co-ordinator:
Mr. Jaideep Goswami, Head of Equities: Email: [email protected] Mr. Abdulkader Puranwala: Phone: +91 22 6807 7339, e-mail: [email protected]
For any clarification, please contact:
Mr. Rushad Kapadia: Phone: +91 22 6807 7334, e-mail: [email protected] Ms. Minali Ginwala: Phone: +91 22 6807 7454, e-mail: [email protected] Ms. Seema Sehgal: Phone: +91 11 4221 8511, e-mail: [email protected]